Laidlaw Wealth Management LLC Geron Corp Transaction History

Laidlaw Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.99 - $1.6 $10,890 - $17,600	-11,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $13,420 - $18,920	11,000 New	11,000 $13,000
Q1 2021 May 17, 2021	SELL	$1.52 - $2.1 $121,562 - $167,947	-79,975 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.59 - $2.19 $22,339 - $30,769	14,050 Added 21.31%	79,975 $139,000
Q2 2020 Aug 19, 2020	SELL	$1.05 - $2.18 $81,681 - $169,586	-77,792 Reduced 54.13%	65,925 $144,000
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $121,056 - $251,336	115,292 Added 405.6%	143,717 $66,000
Q1 2020 May 15, 2020	SELL	$0.89 - $1.49 $1,602 - $2,682	-1,800 Reduced 5.96%	28,425 $34,000
Q4 2019 Feb 14, 2020	BUY	$1.27 - $1.54 $38,385 - $46,546	30,225 New	30,225 $41,000

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.28B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Laidlaw Wealth Management LLC with notifications on news.